Vigil Neuroscience Enrolls First Subject in ALSP Study
Vigil Neuroscience, a biotechnology company harnessing the power of microglia for the treatment of neurodegenerative diseases, announced today the enrollment...
Read More
Vigil Neuroscience hopes to eventually target ALSP
Vigil Neuroscience has revealed the first condition that it will target: a rare, genetic neurodegenerative disorder called ALSP, or adult-onset...
Read More
Vigil Neuro Announces It Is Launching ALSP Programs
Vigil is conducting an observational natural history study with ALSP patients to better understand the disease and help us inform...
Read More
Bone Marrow Transplant Study on Treatment of CSF1R-Related Leukoencephalopathy
This is the largest series of patients with CSF1R-related leukoencephalopathy receiving HSCT. The study concludes that HSCT can stabilize the...
Read More
How To Host a Pink Lemonade Fundraiser for Sisters’ Hope Foundation
A lemonade stand fundraiser works best during the summer months. Hot days equals lots of thirsty supporters! What you’ll need...
Read More
